Companies / Maze Therapeutics, Inc. / Activity
Activity — Maze Therapeutics, Inc.
83 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | Bernstein Harold Executive | Sell | Common Stock | $1.50M | -30K -98.84% | 348 <0.01% of shares | medium |
| Jan 7, 2026 | Sohn Catherine A. Director | Sell | Common Stock | $1.05M | -27K -100.00% | 0 0.00% of shares | medium |
| Jan 7, 2026 | Bernstein Harold Executive | Sell | Common Stock | $1.01M | -25K -100.00% | 0 0.00% of shares | medium |
| Feb 2, 2026 | Bernstein Harold Executive | Sell | Common Stock | $383.8K | -8K -58.08% | 6,036 0.01% of shares | medium |
| Mar 10, 2026 | Bernstein Harold Executive | Exercise | Common Stock | $312.6K | +30K | 30,000 0.05% of shares | low |
| Mar 20, 2026 | Bernstein Harold Executive | Sell | Common Stock | $297.0K | -6K -41.07% | 8,839 0.02% of shares | medium |
| Feb 2, 2026 | Bernstein Harold Executive | Sell | Common Stock | $275.3K | -6K -98.34% | 100 <0.01% of shares | medium |
| Jan 7, 2026 | Bernstein Harold Executive | Exercise | Common Stock | $262.1K | +25K | 25,156 0.05% of shares | low |
| Mar 20, 2026 | Bernstein Harold Executive | Sell | Common Stock | $252.3K | -5K -100.00% | 0 0.00% of shares | medium |
| Jan 22, 2026 | Bachrodt Amy Executive | Sell | Common Stock | $227.6K | -5K -27.83% | 12,965 0.02% of shares | medium |
| Jan 7, 2026 | Sohn Catherine A. Director | Exercise | Common Stock | $216.2K | +21K | 20,744 0.04% of shares | low |
| Mar 20, 2026 | Bernstein Harold Executive | Sell | Common Stock | $187.2K | -4K -42.93% | 5,044 <0.01% of shares | medium |
| Feb 2, 2026 | Bachrodt Amy Executive | Sell | Common Stock | $187.1K | -4K -22.88% | 13,701 0.02% of shares | medium |
| Jan 2, 2026 | Bernstein Harold Executive | Sell | Common Stock | $179.2K | -4K -100.00% | 0 0.00% of shares | medium |
| Feb 27, 2026 | Dandekar Atul Executive | Sell | Common Stock | $172.0K | -4K -26.37% | 10,503 0.02% of shares | medium |
| Feb 27, 2026 | Dandekar Atul Executive | Sell | Common Stock | $168.8K | -4K -20.77% | 14,264 0.03% of shares | medium |
| Mar 2, 2026 | Bachrodt Amy Executive | Sell | Common Stock | $168.2K | -4K -22.20% | 12,965 0.02% of shares | medium |
| Mar 20, 2026 | Bernstein Harold Executive | Exercise | Common Stock | $156.3K | +15K | 15,000 0.03% of shares | low |
| Feb 2, 2026 | Bernstein Harold Executive | Exercise | Common Stock | $156.3K | +15K | 15,000 0.03% of shares | low |
| Jan 29, 2026 | Dandekar Atul Executive | Sell | Common Stock | $154.1K | -4K -20.83% | 13,303 0.02% of shares | medium |
| Jan 29, 2026 | Dandekar Atul Executive | Sell | Common Stock | $126.0K | -3K -21.05% | 10,503 0.02% of shares | medium |
| Jan 2, 2026 | Bachrodt Amy Executive | Sell | Common Stock | $102.7K | -3K -16.68% | 12,965 0.02% of shares | medium |
| Jan 6, 2026 | Sohn Catherine A. Director | Sell | Common Stock | $96.3K | -2K -100.00% | 0 0.00% of shares | low |
| Jan 2, 2026 | Bachrodt Amy Executive | Sell | Common Stock | $93.1K | -2K -13.39% | 15,560 0.03% of shares | low |
| Feb 27, 2026 | Dandekar Atul Executive | Exercise | Common Stock | $78.2K | +8K +71.41% | 18,003 0.03% of shares | low |
| Jan 29, 2026 | Dandekar Atul Executive | Exercise | Common Stock | $78.2K | +8K +71.41% | 18,003 0.03% of shares | low |
| Mar 2, 2026 | Bachrodt Amy Executive | Sell | Common Stock | $57.8K | -1K -7.24% | 16,665 0.03% of shares | low |
| Mar 2, 2026 | Bachrodt Amy Executive | Exercise | Common Stock | $52.1K | +5K +38.57% | 17,965 0.03% of shares | low |
| Jan 29, 2026 | Dandekar Atul Executive | Sell | Common Stock | $51.8K | -1K -6.67% | 16,803 0.03% of shares | low |
| Feb 2, 2026 | Bachrodt Amy Executive | Exercise | Common Stock | $50.5K | +5K +37.36% | 17,809 0.03% of shares | low |
| Jan 2, 2026 | Bachrodt Amy Executive | Exercise | Common Stock | $50.0K | +5K +36.42% | 17,965 0.03% of shares | low |
| Jan 2, 2026 | Bernstein Harold Executive | Exercise | Common Stock | $46.2K | +4K | 4,432 <0.01% of shares | low |
| Feb 2, 2026 | Bachrodt Amy Executive | Sell | Common Stock | $34.3K | -736 -5.37% | 12,965 0.02% of shares | low |
| Jan 7, 2026 | Sohn Catherine A. Director | Exercise | Common Stock | $34.2K | +3K +13.88% | 26,920 0.05% of shares | low |
| Jan 7, 2026 | Sohn Catherine A. Director | Exercise | Common Stock | $30.2K | +3K +13.96% | 23,639 0.04% of shares | low |
| Feb 2, 2026 | Bernstein Harold Executive | Sell | Common Stock | $26.5K | -600 -4.00% | 14,400 0.03% of shares | low |
| Jan 22, 2026 | Bachrodt Amy Executive | Exercise | Common Stock | $26.1K | +3K +16.19% | 17,965 0.03% of shares | low |
| Jan 22, 2026 | Bachrodt Amy Executive | Exercise | Common Stock | $26.0K | +2K +19.26% | 15,462 0.03% of shares | low |
| Jan 6, 2026 | Sohn Catherine A. Director | Exercise | Common Stock | $26.0K | +2K | 2,493 <0.01% of shares | low |
| Mar 10, 2026 | Bernstein Harold Executive | Sell | Common Stock | $17.8K | -348 -100.00% | 0 0.00% of shares | low |
| Jan 5, 2026 | Bernstein Harold Executive | Sell | Common Stock | $16.5K | -412 -100.00% | 0 0.00% of shares | low |
| Feb 2, 2026 | Bachrodt Amy Executive | Sell | Common Stock | $8.8K | -200 -1.11% | 17,765 0.03% of shares | low |
| Feb 2, 2026 | Bernstein Harold Executive | Sell | Common Stock | $4.7K | -100 -100.00% | 0 0.00% of shares | low |
| Jan 5, 2026 | Bernstein Harold Executive | Exercise | Common Stock | $4.3K | +412 | 412 <0.01% of shares | low |
| Jan 2, 2026 | Bachrodt Amy Executive | Exercise | Common Stock | $2.1K | +204 +1.57% | 13,169 0.02% of shares | low |
| Feb 2, 2026 | Bachrodt Amy Executive | Exercise | Common Stock | $1.6K | +156 +0.88% | 17,965 0.03% of shares | low |
| May 4, 2026 | Homcy Charles J Director | Gift | Common Stock | $0 | -7K -19.26% | 31,113 0.06% of shares | low |
| Jun 8, 2026 | Lim Jonathan E Director | Grant | Stock Option (Right to Buy) | — | +18K | 18,000 0.03% of shares | low |
| Jun 8, 2026 | Spiegelman Daniel K Director | Grant | Stock Option (Right to Buy) | — | +18K | 18,000 0.03% of shares | low |
| Jun 8, 2026 | Scheller Richard H Director | Grant | Stock Option (Right to Buy) | — | +18K | 18,000 0.03% of shares | low |